Hoth Therapeutics Files 2024 Annual Report
Ticker: HOTH · Form: 10-K · Filed: Mar 28, 2025 · CIK: 1711786
| Field | Detail |
|---|---|
| Company | Hoth Therapeutics, Inc. (HOTH) |
| Form Type | 10-K |
| Filed Date | Mar 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, pharmaceuticals, sec-filing
TL;DR
HOTH filed its 2024 10-K. All systems go for pharma prep.
AI Summary
Hoth Therapeutics, Inc. filed its 10-K for the fiscal year ended December 31, 2024. The company, incorporated in Nevada with its principal executive offices in New York, operates in the Pharmaceutical Preparations sector. The filing covers its annual report and includes details about its business, financial condition, and operations.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Hoth Therapeutics' performance and strategic direction for the fiscal year 2024, crucial for understanding the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Hoth Therapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 1231 — Fiscal Year End (Indicates the end of the reporting period for financial statements.)
- 2024 — Fiscal Year (The period covered by the annual report.)
Key Players & Entities
- Hoth Therapeutics, Inc. (company) — Registrant
- 2024 (date) — Fiscal year end
- Nevada (jurisdiction) — State of incorporation
- New York (location) — Principal executive offices
- 001-38803 (identifier) — Commission file number
FAQ
What is the primary business of Hoth Therapeutics, Inc.?
Hoth Therapeutics, Inc. operates in the Pharmaceutical Preparations sector, as indicated by its Standard Industrial Classification code [2834].
In which state was Hoth Therapeutics, Inc. incorporated?
Hoth Therapeutics, Inc. was incorporated in Nevada.
What is the address of Hoth Therapeutics, Inc.'s principal executive offices?
The principal executive offices of Hoth Therapeutics, Inc. are located at 1177 Avenue of the Americas, 5th Floor, Suite 5066, New York, New York, 10036.
What is the Commission file number for Hoth Therapeutics, Inc.?
The Commission file number for Hoth Therapeutics, Inc. is 001-38803.
For which fiscal year is this 10-K filing?
This 10-K filing is for the fiscal year ended December 31, 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 28, 2025 regarding Hoth Therapeutics, Inc. (HOTH).